Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Meetings
Meetings
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Bronchoscopy Ultrasound and Navigational Bronchoscopy Finally Arrive in Peru
lungcanc
First-Ever IASLC School of Nursing Held at Latin American Lung Cancer Regional Meeting in Mexico City
Scientific Highlights from the IASLC Latin America Conference on Lung Cancer
Societies Join Forces to Host Seventh European Lung Cancer Conference
Highlights from IASLC WCLC 2016
IASLC Targeted Therapies of Lung Cancer Meeting Draws Record Abstract Submissions,...
lungcanc
IASLC World Conference on Lung Cancer 2016 Together Against Lung Cancer
lungcanc
Inaugural Africa Conference: Finding Parallels Among Disparate Realities
lungcanc
IASLC SCLC Meeting Program, Faculty to Reflect the Field’s Pivotal, Recent...
lungcanc
2017 ASCO Annual Meeting
lungcanc
EGFR-Targeted Therapy: A New Beginning
lungcanc
IASLC 2019 Mesothelioma Meeting Offers Innovative Approach for Rapid Learning
lungcanc
Best of IASLC WCLC 2016
lungcanc
IASLC Small Cell Lung Cancer Workshop
lungcanc
2017 Lung Cancer SPORE Workshop
lungcanc
1
2
3
...
6
Page 1 of 6
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS